raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:231111

Drug-induced lupus erythematosus

Synonyms: DILE

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare, systemic disease with skin involvement characterized by the onset of idiopathic lupus erythematosus-like signs and symptoms resulting from continuous drug intake (>1 month), which resolve when treatment is discontinued, in persons with no history of autoimmune disease. Manifestations are variable and may be systemic (e.g. arthralgia, myalgia, fever, fatigue, serositis, pleuritis, pericarditis), subacute cutaneous (incl. photosensitive, non-scarring, annular, polycyclic or papulosquamous lesions, malar erythema, vasculitis, bullous lesions, erythema multiforme-like changes), and/or chronic cutaneous (typically discoid lesions in sun-exposed areas). Procainamide and hydralazine are the drugs most frequently implicated.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDrug-induced lupus erythematosusDILE
frLupus érythémateux induit par les médicaments= en
deLupus erythematodes, Medikamenteninduzierter= en
esLupus eritematoso inducido por fármacosDILE · Lupus eritematoso inducido por medicamentos
itLupus eritematoso indotto dai farmaci= en
nlMedicatiegeïnduceerde lupus erythematosus= en
ptLupus eritmatoso induzido por fármacos
plToczeń rumieniowaty indukowany lekami= en
csLéky navozený systémový lupus erythematodes= en
ukМедикаментозний червоний вовчак= en
zh药物诱发红斑狼疮= en
trİlaca bağlı lupus eritematoz= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10M32.0Especificvalidated
ICD-114A40.1Especificvalidated
MONDO0016474Evalidated
UMLSC0263591Evalidated
MedDRA10013706Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

23 annotations · validated 2017-07-03
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001903Anemia
HP:0003493Antinuclear antibody positivity
HP:0002829Arthralgia
HP:0030057Autoimmune antibody positivity
HP:0005421Decreased circulating complement C3 concentration
HP:0045042Decreased circulating complement C4 concentration
HP:0002094Dyspnea
HP:0011227Elevated circulating C-reactive protein concentration
HP:0003236Elevated circulating creatine kinase concentration
HP:0003565Elevated erythrocyte sedimentation rate
HP:0000790Hematuria
HP:0003138Increased blood urea nitrogen
HP:0025343Lupus anticoagulant
HP:0025300Malar rash
HP:0003326Myalgia
HP:0001698Pericardial effusion
HP:0001701Pericarditis
HP:0000967Petechiae
HP:0005184Prolonged QTc interval
HP:0001873Thrombocytopenia
Frequent (79-30%)
HP:0001945Fever
HP:0045073Serositis
Occasional (29-5%)
HP:0025142Constitutional symptom

Run the differential on the 12 obligate / very frequent terms

Annotation source: 26420637[PMID]_26710505[PMID]

7

Sources for this card